Mayukh Sukhatme, Pres&Chief Investment Officer at Roivant Sciences Ltd. (ROIV), sold 825,168 shares at $12.05 ($9.9M) on 2024-12-18, disclosed to the SEC on 2024-12-20.
Open-market sale of $9.9M ROIV by Pres&Chief Investment Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.05 | 412,584 | $5.0M | 50.0% |
| 2 | $12.05 | 412,584 | $5.0M | 50.0% |
| Total | $12.05 avg | 825,168 | $9.9M | 100% |
| Filing → |
| ROIV | SELL | 2026-06-29 | $34.1M | — | Filing → |
| ROIV | SELL | 2026-02-11 | $9.0M | — | Filing → |
| ROIV | SELL | 2025-12-31 | $57.8M | — | Filing → |